ARK Genomic Revolution ETF
ARKG
243 hedge funds and large institutions have $761M invested in ARK Genomic Revolution ETF in 2020 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 89 increasing their positions, 32 reducing their positions, and 18 closing their positions.
422% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 18
178% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 32
128% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $994K
58% more capital invested
Capital invested by funds: $483M → $761M (+$278M)
45% more funds holding
Funds holding: 168 → 243 (+75)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
2.86% less ownership
Funds ownership: 36.44% → 33.59% (-2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.7M |
| 2 |
LPL Financial
San Diego,
California
|
+$11.4M |
| 3 |
JCM
Janney Capital Management
Pittsburgh,
Pennsylvania
|
+$9.66M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7.44M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$7.93M |
| 2 |
SCA
Snowden Capital Advisors
New York
|
-$4.69M |
| 3 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$3.14M |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
-$1.97M |
| 5 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$1.6M |
ARKG Hedge Fund Activity: Q3 2020 in Review
243 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2020, worth a combined $761M — up 58% from $483M a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new ARKG positions and 18 closed out — a net gain of 76 holders — while 89 added to existing stakes and 32 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $24.7M. The largest seller was Brinker Capital Investments, exiting entirely with an estimated $7.93M sold.
- 243 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2020, up from 168 in Q2 2020.
- Funds reported $761M of ARK Genomic Revolution ETF stock for Q3 2020, up 58% quarter-over-quarter.
- 94 funds opened new ARK Genomic Revolution ETF positions in Q3 2020 and 18 closed out, a net change of +76 holders.
- The largest ARK Genomic Revolution ETF buyer in Q3 2020 was Morgan Stanley, an estimated $24.7M added.
- The largest ARK Genomic Revolution ETF seller in Q3 2020 was Brinker Capital Investments, an estimated $7.93M sold.
Based on aggregated 13F filings for Q3 2020.